<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>药通社 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-12-21T16:10:49+08:00</updated>
  <subtitle>医药：政策、资讯、产业、发展</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>刚刚！CDE发布《化学仿制药参比制剂目录（第三十六批）》的公示，累计86个参比未通过审议</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/5BRG6vBd9ghS54e168UlIA</id>
    <link href="https://mp.weixin.qq.com/s/5BRG6vBd9ghS54e168UlIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国家局：印度药企GMP整改OK，恢复进口！此前：部分生产工序未按照GMP进行管理、部分关键工艺未经验证</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/T-xohJOcxcG7frJAY9g-QA</id>
    <link href="https://mp.weixin.qq.com/s/T-xohJOcxcG7frJAY9g-QA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新：多家药企申请注销《药品生产许可证》</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/rn1DXny6c2vlpp1fDwsyww</id>
    <link href="https://mp.weixin.qq.com/s/rn1DXny6c2vlpp1fDwsyww" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/yIECfofW9TqrobmoTuzurw</id>
    <link href="https://mp.weixin.qq.com/s/yIECfofW9TqrobmoTuzurw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/Er8HgJaM0a4BEbtXVK-9fQ</id>
    <link href="https://mp.weixin.qq.com/s/Er8HgJaM0a4BEbtXVK-9fQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>华为进军药物研发！医药界幸事！</title>
    <updated>2020-12-21T15:40:49+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-21:/s/aqCR_AJdtK8ghzVZcRoI9g</id>
    <link href="https://mp.weixin.qq.com/s/aqCR_AJdtK8ghzVZcRoI9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>分享 | 创新药物风险投资策略现状研究</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/5VYKAX032w-JTAtvP1WVpQ</id>
    <link href="https://mp.weixin.qq.com/s/5VYKAX032w-JTAtvP1WVpQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>全球骨质疏松症药物研发概览</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/StAaoclUCe87xOBfRw0uCQ</id>
    <link href="https://mp.weixin.qq.com/s/StAaoclUCe87xOBfRw0uCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/meEMOp61VodTRka5hOQGWw</id>
    <link href="https://mp.weixin.qq.com/s/meEMOp61VodTRka5hOQGWw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-20T11:06:59+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-20:/s/eZUhGfhfPYi_x_1t8qI-ZQ</id>
    <link href="https://mp.weixin.qq.com/s/eZUhGfhfPYi_x_1t8qI-ZQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>中国化学会开启会士制度，117位创始会士，43位首届会士名单！一批医药科学家当选！</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/20OJl2-dBo4Mz7M4blTv1g</id>
    <link href="https://mp.weixin.qq.com/s/20OJl2-dBo4Mz7M4blTv1g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【演讲预告】广东国标医药李沙教授：注射剂真溶液一致性评价法规及关键技术要求</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/4rxWAxsCZpGbVYquWhR_NQ</id>
    <link href="https://mp.weixin.qq.com/s/4rxWAxsCZpGbVYquWhR_NQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CDE最新：多个药品纳入拟突破性治疗品种公示</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/0e7rONTWQ4J6Ly0XwuEnjw</id>
    <link href="https://mp.weixin.qq.com/s/0e7rONTWQ4J6Ly0XwuEnjw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-19T20:35:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-19:/s/HjnmgBNAdFg70seqqz_UEw</id>
    <link href="https://mp.weixin.qq.com/s/HjnmgBNAdFg70seqqz_UEw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>12月18日，60个药品批准证明文件待领取，磺达肝癸钠、碘克沙醇、兰索拉唑、咪达唑仑。。。</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/QeSwlH9jjlaXl38TE4IedA</id>
    <link href="https://mp.weixin.qq.com/s/QeSwlH9jjlaXl38TE4IedA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020药融圈分会论坛-后疫情时代的机遇与挑战成功召开！</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/UvKOf8P-ABuehpchU1LLEQ</id>
    <link href="https://mp.weixin.qq.com/s/UvKOf8P-ABuehpchU1LLEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药典委：常用辅料二氧化硅标准修订！</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/8pAWp0pI3ItZBYPTQCdiJw</id>
    <link href="https://mp.weixin.qq.com/s/8pAWp0pI3ItZBYPTQCdiJw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>BE数据严重缺陷，官方暂停34个仿制药上市许可</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/CSTrLDCSCE7DMHKneRZZ7Q</id>
    <link href="https://mp.weixin.qq.com/s/CSTrLDCSCE7DMHKneRZZ7Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>免费参会，议程发布！“华北地区”药物技术峰会暨仿制药一致性评价</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/TlQu9SEP6OzxuIkSCyzfIg</id>
    <link href="https://mp.weixin.qq.com/s/TlQu9SEP6OzxuIkSCyzfIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>制剂、分析、注册、临床岗位，尽在：免费的制药人才网</title>
    <updated>2020-12-18T11:26:18+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-12-18:/s/GSQ40UF9iwBPTKJ4nUY4Vw</id>
    <link href="https://mp.weixin.qq.com/s/GSQ40UF9iwBPTKJ4nUY4Vw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>